These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6249949)

  • 1. Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.
    Aya T; Mizuno F; Osato T
    J Natl Cancer Inst; 1980 Aug; 65(2):265-71. PubMed ID: 6249949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic protection against Epstein-Barr virus induced oncogenesis: cooperative effect of lymphocytes, antibodies and interferon in healthy individuals (author's transl)].
    Aya T
    Hokkaido Igaku Zasshi; 1981 Nov; 56(6):587-96. PubMed ID: 6175556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-dependent autologous lymphocyte cytotoxicity against cells freshly transformed by Epstein-Barr virus.
    Aya T; Matsuo T; Takada K; Osato T; Mizuno F
    IARC Sci Publ (1971); 1978; (24 Pt 2):711-9. PubMed ID: 221393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the growth of Epstein-Barr virus-infected B cells. I. Growth regression by E rosetting cells from VCA-positive donors is a combined effect of autologous mixed leukocyte reaction and activation of T8+ memory cells.
    Konttinen YT; Bluestein HG; Zvaifler NJ
    J Immunol; 1985 Apr; 134(4):2287-93. PubMed ID: 2857749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
    Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of target antigen for antibody-dependent cellular cytotoxicity on cells carrying Epstein-Barr virus genome.
    Takaki K; Harada M; Sairenji T; Hinuma Y
    J Immunol; 1980 Nov; 125(5):2112-7. PubMed ID: 6253564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of HLA-restricted cytotoxic T lymphocytes against autologous Epstein-Barr Virus transformed B lymphoblastoid cell line.
    Fukukawa T; Hirano T; Sakaguchi N; Teranishi T; Tsuyuguchi I; Nagao N; Naito N; Yoshimura K; Okubo Y; Tohda H; Oikawa A
    J Immunol; 1981 May; 126(5):1697-701. PubMed ID: 6163815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of allogeneic restriction of human cytotoxic T cell clones specific for Epstein Barr virus.
    Tanaka Y; Sugamura K; Hinuma Y
    J Immunol; 1982 Mar; 128(3):1241-5. PubMed ID: 6173428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic CD8+ T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro.
    Shi Y; Smith KD; Kurilla MG; Lutz CT
    J Immunol; 1997 Aug; 159(4):1844-52. PubMed ID: 9257848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
    Jondal M
    Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A; Buhmann R; Straka C; Emmerich B; Hallek M
    Bone Marrow Transplant; 1998 May; 21(9):909-16. PubMed ID: 9613783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory of Epstein-Barr virus-specific cytotoxic T cells in normal seropostive adults as revealed by an in vitro restimulation method.
    Tanaka Y; Sugamura K; Hinuma Y; Sato H; Okochi K
    J Immunol; 1980 Oct; 125(4):1426-31. PubMed ID: 6157733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.
    Okugawa K; Itoh T; Kawashima I; Takesako K; Mazda O; Nukaya I; Yano Y; Yamamoto Y; Yamagishi H; Ueda Y
    Oncol Rep; 2004 Oct; 12(4):725-31. PubMed ID: 15375491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
    Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
    Tsokos GC; Magrath IT; Balow JE
    J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
    J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
    Wheatley GH; McKinnon KP; Iacobucci M; Mahon S; Gelber C; Lyerly HK
    Surgery; 1998 Aug; 124(2):171-6. PubMed ID: 9706135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.